This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Supplementary Information (Tables)
This section provides details for each Transfer Payment Program (TPP).
Transfer Payment Program | Forecast Spending 2011–12 |
Planned Spending | ||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Aboriginal Head Start in Urban and Northern Communities | 32.1 | 32.1 | 32.1 | 32.1 |
Canada Prenatal Nutrition Program | 27.2 | 27.2 | 27.2 | 27.2 |
Canadian Diabetes Strategy (non-Aboriginal elements) | 6.2 | 6.3 | 6.3 | 6.3 |
Community Action Program for Children | 53.4 | 53.4 | 53.4 | 53.4 |
Federal Initiative to Address HIV/AIDS in Canada | 22.3 | 24.2 | 24.2 | 24.2 |
Healthy Living Fund | 5.0 | 5.2 | 5.0 | 5.0 |
Innovation Strategy | 11.1 | 11.1 | 11.1 | 11.1 |
National Collaborating Centres for Public Health | 8.3 | 8.3 | 8.3 | 8.3 |
Disclosure of TPPs under $5 Million | — | — | — | — |
Name of Transfer Payment Program: Aboriginal Head Start in Urban and Northern Communities (AHSUNC). This transfer payment is a voted program.
Start Date: 1995–96
End Date: Ongoing
Fiscal Year for Terms & Conditions: 2009–10
Strategic Outcome: Canada is able to promote health, reduce health inequalities, and prevent and mitigate disease and injury
Program Activity: Health Promotion
Description: This program builds capacity by providing funding to Aboriginal community organizations to deliver comprehensive, culturally appropriate, early childhood development programs for Aboriginal preschool children and their families living off-reserve and in urban and northern communities across Canada. It engages stakeholders and supports knowledge development and exchange on promising public health practices for Aboriginal preschoolers through training, meetings and workshops. The primary goal of the program is to mitigate inequities in health and developmental outcomes for Aboriginal children in urban and northern settings by supporting early intervention strategies that cultivate a positive sense of self, a desire for learning, and opportunities to develop successfully as young people. Funded projects offer programming focused on health promotion, nutrition, culture and language, parent and family involvement, social support and educational activities. The program responds to a gap in culturally appropriate programming for Aboriginal children and families living in urban and northern communities. Research confirms that early childhood development programs can provide long-term benefits such as lower costs for remedial and special education, increased levels of high school completion and better employment outcomes. The contribution is not repayable.
Expected Results: Community based organizations funded by AHSUNC promote supportive environments for Aboriginal children and families living in urban and northern communities Performance Indicators include
Forecast Spending 2011–12 |
Planned Spending | |||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Total Contributions | 32.1 | 32.1 | 32.1 | 32.1 |
Total Transfer Payments | 32.1 | 32.1 | 32.1 | 32.1 |
Fiscal Year of Last Completed Evaluation: A national impact evaluation was completed in 2006.
Decision following the Results of Last Evaluation: Continuation
Fiscal Year of Planned Completion of Next Evaluation: An evaluation is scheduled to be completed in 2011–12.
General Targeted Recipient Group: Aboriginal community-based organizations serving First Nations, Métis and Inuit children and their families living in urban and northern communities across Canada.
Initiatives to Engage Applicants and Recipients: Recipients are engaged through targeted solicitations. Funded recipients deliver comprehensive, culturally appropriate, locally controlled and designed early childhood development programs for Aboriginal pre-school children and their families living in urban and northern communities across Canada. They also support knowledge development and exchange at the community, provincial/territorial and national levels through training, meeting and exchange opportunities.
Name of Transfer Payment Program: Canada Prenatal Nutrition Program (CPNP). This transfer payment is a voted program.
Start Date: 1994–95
End Date: Ongoing
Fiscal year for Terms & Conditions: 2009–10
Strategic Outcome: Canada is able to promote health, reduce health inequalities, and prevent and mitigate disease and injury
Program Activity: Health Promotion
Description: This program builds capacity by providing funding to community organizations to deliver and enable access to programs that promote the health of vulnerable pregnant women and their infants. The program also supports knowledge development and exchange on promising public health practices related to maternal-infant health for vulnerable families, community-based organizations and practitioners. The goal of the program is to mitigate inequities in health for pregnant women and infants who face challenging life circumstances such as low socioeconomic status, lack of food security, social and geographic isolation. Evidence shows that maternal nutrition, social and emotional support can affect both prenatal and infant health, as well as longer-term physical, cognitive and emotional functioning in adulthood. This program raises stakeholder awareness of and support a coherent, evidence-based response to the needs of vulnerable children and families on a local and national scale. Programming delivered across the country includes nutrition counselling, prenatal vitamins, food and food coupons, parenting classes, education on prenatal health, infant care, child development, healthy living and social supports. The contribution is not repayable.
Expected Results: Community-based organizations funded by CPNP promote supportive environments for pregnant women, infants, and families living in conditions of risk.
Performance measures include:
Forecast Spending 2011–12 |
Planned Spending | |||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Total Contributions | 27.2 | 27.2 | 27.2 | 27.2 |
Total Transfer Payments | 27.2 | 27.2 | 27.2 | 27.2 |
Fiscal Year of last Completed Evaluation: The Summative Evaluation of the Canada Prenatal Nutrition Program 2004-2009 was completed in January 2010.
Decision following the Results of Last Evaluation: Continuation
Fiscal Year of Planned Completion of Next Evaluation: The program will undergo its next evaluation in 2016–17.
General Targeted Recipient Group: Community-based organizations serving vulnerable pregnant women and infants.
Initiatives to Engage Applicants and Recipients: Knowledge development and exchange, and engagement in strategic projects on emerging issues via CAPC/CPNP National Projects Fund. Partnerships and training opportunities.
Name of Transfer Payment Program: Canadian Diabetes Strategy (non-Aboriginal elements) (CDS). This transfer payment is a voted program.
Start Date: 2005–06
End Date: Ongoing
Fiscal Year for Terms and Conditions: 2009–10
Strategic Outcome: Canada is able to promote health, reduce health inequalities, and prevent and mitigate disease and injury
Program Activity: Disease and Injury Prevention and Mitigation
Description: The Diabetes Program supports the prevention, early detection and management of diabetes among at risk and underserved populations by providing stakeholders with relevant, evidence-based tools and resources, generated through funding agreements with community-based and non-profit organizations. Dissemination of the learnings from these projects enables stakeholders to incorporate evidence-based knowledge into the design and implementation of public health policies and programs. Through leadership, the program facilitates partnerships of government and non-government organizations, as well as private industry to ensure that resources are deployed to maximum effect. It responds to the rising incidence of diabetes due to an increasingly inactive and overweight Canadian population and is based on evidence demonstrating that late diagnosis and poor self-management of diabetes can lead to serious complications such as kidney and heart disease. The program is geared toward intermediaries who support those most at risk of the disease including Aboriginal peoples living off-reserve, some ethno-cultural communities and low-income Canadians. The goal is to reduce the severity and burden of diabetes and its complications by increasing access to evidence-based knowledge and interventions that enable intermediaries to support the prevention, early detection and management of diabetes among at risk and underserved populations through improved screening and multi-disciplinary support. This contribution is not repayable.
Expected Results:
Performance measures include:
Forecast Spending 2011–12 |
Planned Spending | |||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Total Grants | 1.2 | 1.2 | 1.2 | 1.2 |
Total Contributions | 5.0 | 5.1 | 5.1 | 5.1 |
Total Transfer Payments | 6.2 | 6.3 | 6.3 | 6.3 |
Fiscal Year of last Completed Evaluation: An evaluation on the CDS for the period 2004–09 was completed in February 2010 as part of the Promotion of Population Health Grant and Contribution Programs: Summary of Program Evaluations, 2004-2009.
Decision following the Results of Last Evaluation: Continuation
Fiscal Year of Planned Completion of Next Evaluation: Evaluations of the grants and contributions components of Chronic Diseases Prevention and Mitigation (including the Integrated Strategy on Healthy Living and Chronic Disease) are planned for 2014–15.
General Targeted Recipient Group: Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; and organizations and institutions supported by provincial and territorial governments.
Initiatives to Engage Applicants and Recipients: Open G&C solicitations posted on PHAC Web site, targeted G&C solicitations amongst regional or national networks, recipient in person or teleconference meetings to promote collaboration, evaluation and knowledge synthesis, development of case studies to share learnings from funded projects.
Name of Transfer Payment Program: Community Action Program for Children (CAPC). This transfer payment is a voted program.
Start Date: 1993–94
End Date: Ongoing
Fiscal Year for Terms & Conditions: 2009–10
Strategic Outcome: Canada is able to promote health, reduce health inequalities, and prevent and mitigate disease and injury
Program Activity: Health Promotion
Description: This program builds capacity by providing funding to community organizations to deliver and enable access to programming that promotes the healthy development of vulnerable children (0–6 years) and their families. The program also supports knowledge development and exchange on promising public health practices for vulnerable families, community-based organizations and practitioners. The goal of the program is to mitigate inequities in health for vulnerable children and families facing challenging life circumstances such as low socio-economic status, and social and geographic isolation. Compelling evidence shows that risk factors affecting the health and development of children can be mitigated over the life-course by investing in early intervention services that address the needs of the whole family. This program raises stakeholder awareness and supports a coherent, evidence-based response to the needs of vulnerable children and families on a local and national scale. Programming across the country may include education on health, nutrition, early childhood development, parenting, healthy living and social supports. The contribution is not repayable.
Expected Results: Community-based organizations funded by CAPC promote supportive environments for children and families living in conditions of risk.
Performance Indicators include:
Forecast Spending 2011–12 |
Planned Spending | |||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Total Contributions | 53.4 | 53.4 | 53.4 | 53.4 |
Total Transfer Payments | 53.4 | 53.4 | 53.4 | 53.4 |
Fiscal Year of last Completed Evaluation: The Summative Evaluation of the Community Action Program for Children: 2004-2009 was completed in January 2010.
Decision following the Results of Last Evaluation: Continuation
Fiscal Year of Planned Completion of Next Evaluation: The program will undergo its next evaluation in 2016–17.
General Targeted Recipient Group: Community based organizations serving vulnerable children (0–6) and their families.
Initiatives to Engage Applicants and Recipients: Knowledge development and exchange and engagement in national strategic projects on emerging issues via CAPC/CPNP National Projects Fund. Partnerships and training opportunities.
Name of Transfer Payment Program: Federal Initiative to Address HIV/AIDS in Canada (FI). The transfer payment is a voted program.
Start Date: January 2005
End Date: Ongoing
Fiscal Year for Terms and Conditions: 2009–10
Strategic Outcome: Canada is able to promote health, reduce health inequalities, and prevent and mitigate disease and injury
Program Activity: Disease and Injury Prevention and Mitigation
Description: Contributions towards the Federal Initiative to Address HIV/AIDS in Canada. The contribution is not repayable.
Expected Results: Projects funded at the national and regional levels will result in:
Forecast Spending 2011–12 |
Planned Spending | |||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Total Grants | 5.5 | 7.4 | 7.4 | 7.4 |
Total Contributions | 16.8 | 16.8 | 16.8 | 16.8 |
Total Transfer Payments | 22.3 | 24.2 | 24.2 | 24.2 |
Fiscal Year of last Completed Evaluation: In 2009–10 the Federal Initiative to Address HIV/AIDS in Canada Implementation Evaluation Report (2004–07) was approved.
Decision following the Results of Last Evaluation: Continuation
Fiscal Year of Planned Completion of Next Evaluation: The next evaluation of the FI to Address HIV/AIDS in Canada is planned for completion by 2013–14.
General Targeted Recipient Group: Canadian not-for-profit voluntary organizations and corporations; unincorporated groups, societies and coalitions; provincial territorial regional and local governments and agencies; organizations and institutions supported by provincial and territorial governments.
Initiatives to Engage Applicants and Recipients: Applicants and recipients are engaged through performance measurement and evaluation processes, and periodic meetings with stakeholders involved in the prevention and control of communicable diseases.
Name of Transfer Payment Program: Healthy Living Fund (HLF). The transfer payment is a voted program.
Start date: June 2005
End date: Ongoing
Fiscal Year for Terms and Conditions: 2009–10
Strategic Outcome: Canada is able to promote health, reduce health inequalities, and prevent and mitigate disease and injury.
Program Activity: Health Promotion
Description: The HLF supports healthy living activities with community, regional, national and international impacts by funding and engaging the voluntary sector, and by building partnerships between and collaborating with governments, non-governmental organizations and other agencies. The contribution is not repayable.
Expected results: Funds will be used to build public health capacity and develop supportive environments for physical activity and healthy eating. Projects will help to strengthen the evidence base, contribute to knowledge development and exchange and help in the formation of health promotion activities.
Performance measures include:
Forecast Spending 2011–12 |
Planned Spending | |||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Total Contributions | 5.0 | 5.2 | 5.0 | 5.0 |
Total Transfer Payments | 5.0 | 5.2 | 5.0 | 5.0 |
Fiscal Year of last Completed Evaluation: A formative evaluation was completed in March 2009–10.
Decision following the Results of Last Evaluation: The Healthy Living Program is relevant, necessary and generally well formulated.
Fiscal Year of Planned Completion of Next Evaluation: An evaluation is scheduled to be completed in 2014–15.
General Targeted Recipient Group: Canadian not-for-profit voluntary organizations and corporations; unincorporated groups, societies and coalitions; provincial, territorial, regional, and municipal governments and agencies; organizations and institutions supported by provincial and territorial governments (regional health authorities, schools, post secondary institutions, etc.); and individuals deemed capable of conducting population health activities.
Initiatives to Engage Applicants and Recipients: Recipients are engaged through open, targeted and directed solicitations. Funded recipients engage at the community, provincial/territorial and national levels through training, meeting and exchange opportunities.
Name of Transfer Payment Program: Innovation Strategy (IS). This transfer payment is a voted program.
Start Date: 2009–10
End Date: Ongoing
Fiscal Year for Terms and Conditions: 2009–10
Strategic Outcome: Canada is able to promote health, reduce health inequalities, and prevent and mitigate disease and injury
Program Activity: Health Promotion
Description: This program enables the development, implementation and evaluation of innovative public health interventions to reduce health inequalities and their underlying factors by providing project funding support to external organizations in a variety of sectors such as health and education. It focuses on priority public health issues such as mental health promotion and achieving healthier weights. The program fills a need by stakeholders such as public health practitioners, decision makers, researchers and policy makers for evidence on innovative public health interventions which directly benefit Canadians and their families, particularly those at greater risk of poor health outcomes (e.g., northern, remote and rural populations). Evidence is developed, synthesized and shared with stakeholders in public health and other related sectors at the community, provincial/territorial and national levels in order to influence the development and design of policies and programs. This program is necessary because it enables stakeholders to implement evidence-based and innovative public health interventions that fit local needs. The goals of the program are to stimulate action in priority areas and equip policy makers and practitioners to apply best practices. The contribution is non repayable.
Expected Results:
Forecast Spending 2011–12 |
Planned Spending | |||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Total Grants | 7.3 | 7.3 | 7.3 | 7.3 |
Total Contributions | 3.8 | 3.8 | 3.8 | 3.8 |
Total Transfer Payments | 11.1 | 11.1 | 11.1 | 11.1 |
Fiscal Year of last Completed Evaluation: The Population Health Fund Evaluation 2008 covering the period of 2005–08 was completed in 2009.
Decision following the Results of Last Evaluation: Continuation as Innovation Strategy
Fiscal Year of Planned Completion of Next Evaluation: The next evaluation is planned for completion by 2014–15
General Targeted Recipient Group: Canadian not-for-profit voluntary organizations and corporations; unincorporated groups, societies and coalitions; provincial, territorial, regional and municipal governments and agencies; organizations and institutions supported by provincial and territorial governments; and individuals deemed capable of conducting population health activities.
Initiatives to Engage Applicants and Recipients: Open and targeted calls for proposals are utilized to solicit proposals from potential applicants. Various approaches are used to engage applicants and optimize the quality of submitted proposals, including information events and tools and resources. The Innovation Strategy places a high priority on and supports the systematic collection of learnings and the sharing of this information between funded recipients, PHAC and other partners to influence future program and policy design.
Name of Transfer Payment Program: National Collaborating Centres for Public Health (NCCPH). The transfer payment is a voted program.
Start Date: 2004–05
End Date: Ongoing
Fiscal year for Terms and Conditions: 2009–10
Strategic Outcome: Canada is able to promote health, reduce health inequalities, and prevent and mitigate disease and injury.
Program Activity: Public Health Preparedness and Capacity
Description: Contributions to persons and agencies to support health promotion projects in community health resource development, training/skill development and research. The focus of the NCCPH program is to strengthen public health capacity, translate health knowledge and research, and promote and support the use of knowledge and evidence by public health practitioners in Canada through collaboration with provincial/territorial and local governments, academia, public health practitioners and non-governmental organizations. The contributions are not repayable.
Expected Results: Improved public health decision-making stemming from:
Forecast Spending 2011–12 |
Planned Spending | |||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
Total Contributions | 8.3 | 8.3 | 8.3 | 8.3 |
Total Transfer Payments | 8.3 | 8.3 | 8.3 | 8.3 |
Fiscal Year of last Completed Evaluation: The Formative Evaluation of the National Collaborating Centres for Public Health Program (NCCPH) was completed in 2008–09.
Decision following the Results of Last Evaluation: Continuation
Fiscal Year of Planned Completion of Next Evaluation: An evaluation of Public Health Tools, including the National Collaborating Centres for Public Health, is planned for completion by 2013–14.
General Targeted Recipient Group: Six Centres focusing on thematic areas and priorities of public health located within host organizations in non-profit, academic and provincial government settings.
Initiatives to Engage Applicants and Recipients: Program does not anticipate issuing further solicitations. Six Contribution Agreements are in place to 2014–15.
Main Objective | End Date of TPP, if applicable | Type of TP | Forecast Spending for 2012–13 ($M) |
Fiscal Year of Last completed Evaluation | General Targeted Recipient Group |
---|---|---|---|---|---|
Name of TPP: Active and Safe Injury Prevention Initiative | |||||
The Active and Safe injury prevention initiative is aimed at decreasing the number of sport and recreation injuries in children and youth ages 0 to 19. | March 31, 2013 | Contribution | 4.0 | N/A | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Blood Safety | |||||
Support provincial and territorial transfusion and/or transplantation adverse event surveillance activities. | Ongoing | Contribution | 2.2 | 2009–10 | Provincial and territorial governments; transfusion and/or transplantation centres and agencies and/or groups designated by provincial and territorial Ministries of Health; and Canadian not-for-profit organizations who support transfusion adverse event surveillance activities. |
Name of TPP: Canadian Breast Cancer Initiative | |||||
Support networks of community organizations to share best practices in breast cancer and women's health to ensure that information and supports are available to communities. | Ongoing | Grant and Contribution | 0.6 | 2008–09 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Canadian HIV Vaccine Initiative | |||||
Contribute to the global effort to develop a safe, effective, affordable and globally accessible HIV vaccine. | March 31, 2017 | Contribution | 1.3 | 2010–11 | Canadian not-for-profit voluntary organizations and corporations; provincial, territorial and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Fetal Alcohol Spectrum Disorder (FASD) National Strategic Projects Fund | |||||
Assist organizations that have the capacity to enhance and build on already existing FASD activities across the country, and to create new capacity where no previous capacity exists. | Ongoing | Contribution | 1.5 | 2008–09 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Hepatitis C Prevention, Support and Research Program | |||||
Projects funded at the national and regional levels will: contribute to prevention of HCV in Canada and around the world; support persons infected with, affected by, at risk of and/or vulnerable to HCV; provide a stronger evidence base for policy and programming decisions; and strengthen partners' capacity to address HCV in Canada. | Ongoing | Grant and Contribution | 3.5 | 2006–07 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Integrated Strategy for Healthy Living and Chronic Disease – Cancer | |||||
Contribute to cancer prevention, particularly among vulnerable and underserved populations. By testing innovative models for increasing cancer prevention, projects identify best practices that can be replicated across the country. | Ongoing | Grant and Contribution | 4.3 | 2009–10 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Integrated Strategy for Healthy Living and Chronic Disease – Cardiovascular Disease Program | |||||
Contribute to the reduction of the severity and burden of CVD by increasing access to information and knowledge for health professionals and the public about CVD prevention. | Ongoing | Grant and Contribution | 1.4 | 2009–10 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Integrated Strategy for Healthy Living and Chronic Disease – Enhanced Surveillance for Chronic Disease | |||||
Enhance capacity for public health chronic disease surveillance activities to expand data sources for chronic disease surveillance. | Ongoing | Grant and Contribution | 2.4 | 2009–10 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Integrated Strategy for Healthy Living and Chronic Disease – Healthy Living Fund Knowledge Development | |||||
Healthy Living Knowledge Development and Exchange is a central health promotion function that creates a platform for evidence-based action on healthy living. It focuses on informing policy and program decision-making through knowledge capacity development, new knowledge development, knowledge synthesis, and ongoing national and international dissemination and exchange. | Ongoing | Contribution | 0.7 | 2009–10 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups, societies and coalitions; provincial, territorial, regional, and municipal governments and agencies; organizations and institutions supported by provincial and territorial governments (regional health authorities, schools, post secondary institutions, etc.); and individuals deemed capable of conducting population health activities. |
Name of TPP: Integrated Strategy for Healthy Living and Chronic Disease – Joint Consortium for School Health | |||||
Strengthen federal leadership efforts to promote health and prevent chronic disease among school-aged children, and to better align policy and program contributions, both within the federal health portfolio (Health Canada PHAC, CIHR and related agencies) and throughout the Government of Canada. | Ongoing | Grant | 0.3 | N/A | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Integrated Strategy for Healthy Living and Chronic Disease – Observatory of Best Practices | |||||
Build collaborative linkages, nationally and internationally, between researchers, policymakers and practitioners for the purpose of increasing the adoption of effective practices. | Ongoing | Grant and Contribution | 0.2 | 2009–10 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: National Projects Fund: CAPC-CPNP | |||||
Supports time-limited national initiatives that support vulnerable children, pregnant women and families through public health knowledge development, translation and exchange, and by supporting collective community action on public health issues. | Ongoing | Contribution | 1.9 | 2009–10 | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Neurological Diseases | |||||
Improve current knowledge about the incidence, prevalence, co-morbidities, risk factors and the impacts on the use of health services and the economy of neurological conditions in Canada. | March 31,2014 | Contribution | 3.4 | N/A | Canadian not-for-profit voluntary organizations and corporations; unincorporated groups; societies and coalitions; provincial, territorial, and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Preparedness for Avian and Pandemic Influenza – Capacity for Pandemic Preparedness | |||||
Increase public health workforce capacity by fostering excellence in public health professional development. Stimulate knowledge development and transfer. Build infrastructure capacity. Sustain and strengthen emergency preparedness and response capacity. Strengthen public health collaboration. | Ongoing | Grant and Contribution | 0.2 | 2010–11 | Canadian not-for-profit voluntary organizations and corporations; provincial, territorial and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Preparedness for Avian and Pandemic Influenza – Influenza Research Network | |||||
Develop and test methodologies/ methods related to the evaluation of influenza vaccines as they pertain to safety, immunogenicity and effectiveness, and program implementation and evaluation. | Ongoing | Grant | 1.5 | 2010–11 | Canadian not-for-profit voluntary organizations and corporations; provincial, territorial and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Name of TPP: Public Health Scholarship and Capacity Building Initiative | |||||
To increase the number and skills of public health professionals; To enhance relationships between university programs in public health and public health organizations; and, To develop public health training products and tools. |
Ongoing | Grant and Contribution | 3.3 | 2010–11 | Grants for Scholarships and Fellowships will be made available to eligible Canadian citizens and landed immigrants who are resident in Canada or abroad. Grants for public health faculty positions (Chairs) and community medicine resident slots will be made to Canadian post-secondary institutions. Contribution funds will be available for approved proposals that contribute to enhancing public health workforce development and strengthening the capacity and knowledge of the public health sector to deal with public health issues. The class of recipients includes: Canadian not-for-profit voluntary organizations and corporations; provincial, territorial and local governments and agencies; organizations and institutions supported by provincial and territorial governments (regional health authorities or districts, post-secondary institutions, etc.); and individuals, deemed capable of conducting public health activities. |
Name of TPP: Skilled National Public Health Workforce | |||||
Enhance the capacity of the public health system by increasing capacity in systems and tools. | Ongoing | Grant | 0.2 | 2010–11 | Canadian not-for-profit voluntary organizations and corporations; provincial, territorial and local governments and agencies; organizations and institutions supported by provincial and territorial governments. |
Notes:
1 A standard definition for "usage" for the Agency is not currently available, and in relation to this Expected Result, it was intentionally left broad in order to allow flexibility in the development of a measurement tool. This tool could build on some existing work (Skinner 2007) looking at measuring knowledge exchange outcomes, which view a similar concept of Uptake as "reflecting behavioural efforts to use the materials." This is consistent with the PHAC Strategic Plan, 2007–2012, which notes: "The information that the Agency is collecting and managing must be translated into useful knowledge and shared for the benefit of decision-makers and stakeholders... Furthermore, the information that is gathered through PHAC's programs must be translated into useful knowledge that can be used by other programs and our partners and stakeholders across the country" (page 16). The target/tolerance of high / medium / low will be interpreted as an index of stakeholder ratings of several key aspects of 'usage' through a survey tool to be developed at a later date.
The Greening Government Operations (GGO) table applies to departments and agencies bound by the Federal Sustainable Development Act, the Policy on Green Procurement, or the Policy Framework for Offsetting Greenhouse Gas Emissions from Major International Events. RPP refers to Report on Plans and Priorities and DPR refers to Departmental Performance Report.
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Number of completed new construction, build-to-lease and major renovation projects in the given fiscal year, as per departmental strategic framework | 1 | |
Number of completed new construction, build-to-lease and major renovation projects that have achieved an industry-recognized level of high environmental performance in the given fiscal year, as per departmental strategic framework | 1 | |
Existence of strategic framework | Yes |
Strategies / Comments
Performance Measure | RPP | DPR | |
---|---|---|---|
Target Status | |||
Number of buildings over 1,000m2, as per departmental strategic framework | 3 | ||
Percentage of buildings over 1,000m2 that have been assessed using an industry-recognized assessment tool, as per departmental strategic framework | FY 2011–12 | 0 | |
FY 2012–13 | 3 | ||
FY 2013–14 | 3 | ||
Existence of strategic framework | Yes |
Strategies / Comments
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Number of completed lease and lease renewal projects over 1,000m2 in the given fiscal year, as per departmental strategic framework | Not Applicable | |
Number of completed lease and lease renewal projects over 1,000m2 that were assessed using an industry-recognized assessment tool in the given fiscal year, as per departmental strategic framework | Not Applicable | |
Existence of strategic framework | Yes |
Strategies / Comments
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Number of completed fit-up and refit projects in the given fiscal year, as per departmental strategic framework | 0 | |
Number of completed fit-up and refit projects that have achieved an industry-recognized level of high environmental performance in the given fiscal year, as per departmental strategic framework | 0 | |
Existence of strategic framework | Yes |
Strategies / Comments
This table is not applicable as PHAC is not included in Annex 4 of the Federal Sustainable Development Strategy Guideline for Target 8.5.
Performance Measure | RPP | DPR | |
---|---|---|---|
Target Status | |||
Existence of implementation plan for the disposal of all departmentally-generated EEE | No | ||
Total number of departmental locations with EEE implementation plan fully implemented, expressed as a percentage of all locations, by the end of the given fiscal year | FY 2011–12 | 23% | |
FY 2012–13 | 60% | ||
FY 2013–14 | 100% |
Strategies / Comments
Performance Measure | RPP | DPR | |
---|---|---|---|
Target Status | |||
Ratio of departmental office employees to printing units in fiscal year 2010–11, where building occupancy levels, security considerations and space configuration allow | 1.8:15 | ||
Ratio of departmental office employees to printing units at the end of the given fiscal year, where building occupancy levels, security considerations and space configuration allow | FY 2011–12 | 4:1 | |
FY 2012–13 | 8:1 | ||
FY 2013–14 | 12:1 |
Strategies / Comments
Performance Measure | RPP | DPR | |
---|---|---|---|
Target Status | |||
Number of sheets of internal office paper purchased or consumed per office employee in the baseline year selected, as per departmental scope | 5900 sheets per full-time employee6 | ||
Cumulative reduction (or increase) in paper consumption, expressed as a percentage, relative to baseline year selected | FY 2011–12 | 0% | |
FY 2012–13 | -10% | ||
FY 2013–14 | -20% |
Strategies / Comments
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Presence of a green meeting guide | Yes |
Strategies / Comments
8.10 As of April 1, 2011, each department will establish at least 3 SMART green procurement targets to reduce environmental impacts.
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Average life of office computers in the Department in fiscal year 2010–11 | 4 years | |
Progress against measure in the given fiscal year | 4 years |
Strategies / Comments
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Percentage of newly purchased and leased printers and multi-functional devices with environmental features in the 2010–11 fiscal year | 100% | |
Progress against measure in the given fiscal year | 90%7 |
Strategies / Comments
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Baseline in 2012–13: Percentage of integrated facsimile machines into multi-functional devices across the Agency |
to be established by December 31, 2012 | |
Progress against measure in the given fiscal year | 100%8 |
Strategies / Comments
8.11 As of April 1, 2011, each department will establish SMART targets for training, employee performance evaluations, and management processes and controls, as they pertain to procurement decision-making.
Training for Select Employees
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Baselines established in 2009–10: | ||
% of Asset and Materiel Management employees with Canadian School of Public Service (CSPS) C215 certification | 73% | |
% of Asset and Materiel Management contracting specialists with CSPS C215 certification | 83% | |
% of Acquisition Card Holders with PHAC Mandatory Procurement Training | 83% | |
Progress against measure in the given fiscal year: | ||
% of Asset and Materiel Management employees with Canadian School of Public Service (CSPS) C215 certification | 80%9 | |
% of Asset and Materiel Management contracting specialists with CSPS C215 certification | 80%9 | |
% of Acquisition Card Holders with PHAC Mandatory Procurement Training | 100% |
Strategies / Comments
Employee performance evaluations for managers and functional heads of procurement and materiel management
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Baselines established in 2009–10: % of all managers and function heads (three employees) of procurement and materials with environmental consideration clauses incorporated into their performance evaluations | 100% | |
Progress against measure in the given fiscal year | 100% |
Strategies / Comments
Management processes and controls
Performance Measure | RPP | DPR | |
---|---|---|---|
Target Status | |||
% of contracts and services with 'unknown attributes' | 3,171 of 4,853 contracts = 65% | ||
Progress against measure in the given fiscal year | FY 2010–11 | -2% | + 29% |
FY 2011–12 | -2% | ||
FY 2012–13 | -3% | ||
FY 2013–14 | -3% |
Strategies / Comments
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Quantity of emissions offset in the given fiscal year (Optional for all RPPs) | Not Applicable |
Strategies / Comments
Performance Measure | RPP | DPR |
---|---|---|
Progress against measure in the given fiscal year | ||
Sustainable Development Advocate is appointed | Yes |
Strategies / Comments
Performance Measure | RPP | DPR |
---|---|---|
Target Status | ||
Baselines established in 2009–10: | ||
% of annual departmental compliance with the Cabinet Directive for SEA Preliminary Scan for Memoranda to Cabinet | 0% | |
% of annual departmental compliance with the Cabinet Directive for SEA Detailed Assessment for Memoranda to Cabinet | Not Applicable | |
% of annual departmental compliance with the Cabinet Directive for SEA Preliminary Scan for Treasury Board Submissions | 19% | |
% of annual departmental compliance with the Cabinet Directive for SEA Detailed Assessment for Treasury Board Submissions | Not Applicable | |
Progress against measure in the given fiscal year: | ||
% of annual departmental compliance with the Cabinet Directive for SEA Preliminary Scan for Memoranda to Cabinet | 90% | |
% of annual departmental compliance with the Cabinet Directive for SEA Detailed Assessment for Memoranda to Cabinet | Not Applicable | |
% of annual departmental compliance with the Cabinet Directive for SEA Preliminary Scan for Treasury Board Submissions | 90% | |
% of annual departmental compliance with the Cabinet Directive for SEA Detailed Assessment for Treasury Board Submissions | Not Applicable |
Strategies / Comments
Performance Measure | RPP | DPR | |
---|---|---|---|
Target Status | |||
# of major PHAC buildings | 13 | ||
# of major PHAC buildings with a fully-implemented Dead Battery | FY 2011–12 | 9 | |
FY 2012–13 | 9 | ||
FY 2013–14 | 13 |
Strategies / Comments
Performance Measure | RPP | DPR | |
---|---|---|---|
Target Status | |||
Baselines established in 2010–11 # of avoidable CO2 tonnes per year by PHAC | 866.95 tonnes/year | ||
Progress against measure in the given fiscal year: # of reduced avoidable CO2 tonnes per year by PHAC |
FY 2011–12 | -700.95 tonnes/year | |
FY 2012–13 | -800.00 tonnes/year | ||
FY 2013–14 | -866.95 tonnes/year |
Strategies / Comments
Performance Measure | RPP | DPR | |
---|---|---|---|
Target Status | |||
% of workstations controlled and operated by a SmartBar | 100% | ||
% of SmartBars installed in the Agency | FY 2011–12 | 100% | |
FY 2012–13 | 100% | ||
FY 2013–14 | 100% |
Strategies / Comments
Notes:
1 This will be demonstrated by achieving Leadership in Energy and Environmental Design (LEED) New Construction (NC) Silver, Green Globes Design 3 Globes, or equivalent.
2 Assessment tools include: Building Owners and Managers Association (BOMA) BESt (Building Environmental Standards), Green Globes or equivalent.
3 Assessment tools include: BOMA BESt, an appropriately tailored BOMA International Green Lease Standard, or equivalent.
4 This will be demonstrated by achieving LEED Commercial Interior Silver, Green Globes Fit-Up 3 Globes, or equivalent.
5 Ratio determined through an audit of the PHAC Print Optimization studies, which include select PHAC locations. This ratio will be updated as additional figures from across Canada are determined.
6 Baseline includes data from the National Capital Region (NCR) only. Once regional information is obtained, the baseline will be adjusted. On average, NCR accounts for approximately 62% of the Agency's population.
7 For this target, progress against measure in the given fiscal year may be lower than the established baseline to allow for surge capacity exceptions during security and emergency management events under specific conditions (i.e., H1N1, SARS)
8 The target is established at 100% for leases expiring in 2012–13 and new leases issued where standalone fax machines are present. Full compliance (100%) with the overall target cannot occur until 2017, in order for all current leases to expire and be replaced.
9 For these targets, progress against measure in the given fiscal year may be lower than the established baseline to allow for security and emergency management considerations under specific conditions.
Name of Horizontal Initiative: Federal Initiative to Address HIV/AIDS in Canada (FI)
Name of Lead Department(s): Public Health Agency of Canada (the Agency)
Lead Department Program Activity: Disease and Injury Prevention and Mitigation
Start Date of the Horizontal Initiative: January 13, 2005
End Date of the Horizontal Initiative: Ongoing
Total Federal Funding Allocation (Start to End Date): Ongoing
Description of the Horizontal Initiative (Including Funding Agreement): The FI strengthens domestic action on HIV and AIDS, builds a coordinated Government of Canada approach, and supports global health responses to HIV and AIDS. It focuses on prevention and access to diagnosis, care, treatment and support for those populations most affected by HIV and AIDS in Canada—people living with HIV and AIDS, men who have sex with men, Aboriginal people, people who use injection drugs, federal inmates, youth, women, and people from countries where HIV is endemic. The FI also supports and strengthens multi-sector partnerships to address the determinants of health. It supports collaborative efforts to address factors which can increase the transmission and acquisition of HIV including sexually transmitted infections (STI) and also addresses co-infection issues with other infectious diseases (e.g., hepatitis C and tuberculosis) from the perspective of disease progression and morbidity in people living with HIV and AIDS. People living with and vulnerable to HIV and AIDS are active partners in Federal Initiative policies and programs.
Shared Outcome(s):
First level outcomes
Second level outcomes
Ultimate outcomes
Governance Structure(s):
The Responsibility Centre Committee (RCC) is the governance body for the FI. It is comprised of directors from the nine Responsibility Centres which receive funding through the FI. Led by the Agency, the RCC promotes policy and program coherence among the participating departments and agencies, and ensures that evaluation and reporting requirements are met.
The Agency is the federal lead for issues related to HIV and AIDS in Canada responsible for overall coordination, communications, social marketing, reporting, evaluation, national and regional programs, policy development, surveillance and laboratory science.
Health Canada (HC) supports community-based HIV and AIDS education, capacity-building, and prevention for First Nations on-reserve and Inuit communities south of the 60th degree parallel and provides leadership on international health policy and program issues.
As the Government of Canada's agency for health research, the Canadian Institutes of Health Research (CIHR) sets priorities for and administers the extramural research program.
Correctional Service Canada (CSC), an agency of the Public Safety Portfolio, provides health services (including services related to the prevention, diagnosis, care and treatment of HIV and AIDS) to offenders sentenced to two years or more.
Planning Highlights: In 2012–13, together with stakeholders, federal partners will strengthen their response on HIV and AIDS and other infectious diseases with new agreements to coordinate and deliver programs, research and services to prevent and control HIV and AIDS, other STBBI, and TB among First Nations, Inuit and Métis and other key priority populations. Content and related support for AIDS 2012 (Washington) and other key forums, and engagement with civil society and other stakeholders will advance policy priorities and technical responses to communicable diseases and broader public health issues. The coherence of national action to prevent and control HIV and AIDS and related communicable diseases will be increased through the 2012–2014 National HIV/AIDS Voluntary Sector Response Fund and other community based programming.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Science and Technology for Public Health | HIV/AIDS Reference Testing and Quality Assurance | Ongoing | 3.1 | ER 1.1 ER 1.2 |
Surveillance and Population Health Assessment | Surveillance of Infectious Disease | Ongoing | 4.9 | ER 2.1 ER 2.2 |
Disease and Injury Prevention and Mitigation | Infectious Disease Prevention and Control and Community Associated Infections | Ongoing | 37.4 | ER 3.1 ER 3.2 ER 3.3 |
Total Agency | 45.4 |
Expected Results for 2012–13:
ER 1.1: Public health decisions and interventions are supported by timely, reliable and accredited reference service testing that accurately captures all the circulating HIV strains in Canada and directs attention to new outbreaks of HIV. This ensures effective identification and testing for emerging strains of HIV; enhance quality, reliability and comparability of HIV testing.
ER 1.2: Use of laboratory-generated knowledge is increased to: develop diagnostic, prognostic and drug resistance testing standards; provide quality assurance and performance standardization services for regional laboratories; determine changes in the patterns of HIV transmission; and reduce transmission of HIV from mothers to their infants through the identification of optimal and affordable antiviral therapies.
ER 2.1: Increased knowledge and awareness of risk behaviours to inform and guide the development of policies, prevention and care programs for key priority populations including populations in the North by pursuing the implementation of behavioural surveillance of Aboriginal populations (e.g. Yukon).
ER 2.2: Enhance national public health surveillance to address HIV and AIDS among specific ethno-cultural populations (people from countries where HIV is endemic) to contribute to existing surveillance prevention and other programmatic efforts for diseases related to migration by initiating work with federal and provincial partners on the surveillance of people from HIV endemic countries.
ER 3.1: Expanded evidence base, knowledge and awareness of the nature and methods to address HIV and AIDS in key priority populations, to inform ongoing research, policy initiatives and priorities; facilitate knowledge translation and exchange on the evidence linking communicable diseases and the determinants of health; and help identify promising and innovative community-based practices. Timely, reliable, and evidence-informed clinical recommendations for health care providers and public health professionals guide individual and population-based approaches for the detection and management of HIV infection and other related sexually transmitted infections (STIs). This includes upstream scientific evidence with respect to emerging HIV prevention technologies, HIV acquisition and transmission risk, and risks associated with co-infection, as well as primary care information and capacity for the screening, testing, treatment, and management of STIs.
ER 3.2: Enhanced engagement and collaboration on approaches to address HIV and AIDS with respect to Government of Canada policy and program development (domestic and international), and common communicable diseases prevention and control goals of First Nations, Inuit and Métis.
ER 3.3: Increased individual and organizational capacity to address HIV and AIDS.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Internal Services | Governance and Management Support Services | Ongoing | 1.1 | ER 4.1 |
First Nations and Inuit Primary Health Care |
Bloodborne Diseases and Sexually Transmitted Infections — HIV/AIDS | Ongoing | 4.5 | ER 5.1 ER 5.2 |
Total HC | 5.6 |
Expected Results for 2012–13:
ER 4.1: Increased Canadian engagement and leadership in the global context through exchanging best practices with global partners. This will inform global and domestic policy discussion on HIV and AIDS in three global fora and promote policy coherence across the federal government's global activities on HIV and AIDS.
ER 5.1: Increased knowledge and awareness among First Nations, Inuit and/or Métis youth on the nature of HIV and AIDS and ways to address the disease. Determine effective evaluation approaches for sexual health promotion tools, evaluate the pilot Youth Messaging Initiative, and identify best practices related to wellness-type service delivery models in the provision of more holistic and comprehensive health services (HIV and other communicable diseases as well as mental health and substance abuse) to those at greatest risk.
ER 5.2: Enhanced engagement and collaboration on approaches to address HIV/AIDS through ongoing support to the International Indigenous Working Group on HIV/AIDS.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Health and Health Services Advances | HIV and AIDS Research Initiative | Ongoing | 21.0 | ER 6.1 ER 6.2 ER 6.3 |
Total CIHR | 21.0 |
Expected Results for 2012–13:
ER 6.1: Increased knowledge and awareness of the nature of HIV and ways to address the disease through the development and administration of diverse HIV research funding programs. The funding programs will support biomedical, clinical and social science contributing to the development and evaluation of drugs, programs and services for people living with and at risk for HIV/AIDS. In 2012–13, new funding and funding programs will focus on the eradication of HIV, strengthening Canada's network of clinical investigators and addressing co-morbidities for people living with HIV in Canada.
ER 6.2: A strong and diverse HIV research community with the capacity to advance HIV research from biomedical science to community-based projects through support for training and salary award programs as well as multidisciplinary research networks.
ER 6.3: Enhanced coordination and strategic alignment of HIV research with national and international health research priorities and initiatives through the leadership and involvement of CIHR and Canadian researchers. Better coordination and strengthened partnerships will enhance resources for priority topics and help ensure effective application of new knowledge.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Custody | Institutional Health Services Public Health Services | Ongoing | 4.2 | ER 7.1 ER 7.2 |
Total CSC | 4.2 |
Expected Results for 2012–13:
ER 7.1: Increased knowledge and awareness of the nature of HIV and AIDS and ways to address the disease, as achieved through: research and surveillance studies undertaken; tools and knowledge products developed and disseminated through publications, presentations and workshops; and as indicated by the percentage of federal offenders completing HIV and AIDS awareness programming.
ER 7.2: Enhanced engagement and collaboration on approaches to address HIV and AIDS and sexually transmitted and bloodborne infections through the Federal/Provincial/Territorial Heads of Corrections Working Group on Health and CSC's Community Consultation Committee on Public Health. The emphasis will be on developing and strengthening partnerships with: provincial and territorial governments; federal departments at national and regional levels; the Council of Chief Medical Officers of Health, and community partners.
Results to be Achieved by Non-Federal Partners (if Applicable): N/A
Contact Information:
Geneviève Tremblay
100 Eglantine Drive
Ottawa, ON K1A 0K9
613-952-7199
genevieve.tremblay@phac-aspc.gc.ca
Name of Horizontal Initiative: Preparedness for Avian and Pandemic Influenza Initiative
Name of Lead Department(s): Public Health Agency of Canada (the Agency)
Lead Department Program Activities:
Start Date of the Horizontal Initiative: June 21, 2006
End Date of the Horizontal Initiative: Ongoing
Total Federal Funding Allocation (Start to End Date): Ongoing
Description of the Horizontal Initiative (Including Funding Agreement): This initiative is directed at mitigating Canada's risk from two major, inter-related animal and public health threats: the potential spread of avian influenza (AI) virus (i.e., H5N1) to wild birds and domestic fowl in Canada; and, the potential for a human-adapted strain to arise resulting in human-to-human transmission potentially triggering a human influenza pandemic. A coordinated and comprehensive plan to address both avian and pandemic influenza is maintained.
The bulk of the initiative is ongoing. Activities have been launched in the areas of vaccines and antivirals, surge capacity, prevention and early warning, emergency preparedness, critical science and regulation, risk communication, and inter-jurisdictional collaboration. To enhance the federal capacity to address an on-reserve pandemic, efforts have been made to increase surveillance and risk assessment capacity to fill gaps in planning and preparedness.
Shared Outcome(s):
Immediate Outcomes
Intermediate Outcomes
Long-Term and Strategic Outcomes
Governance Structure(s):
In January 2008, the Agency, the Canadian Food Inspection Agency and Health Canada finalized the Avian and Pandemic Influenza Preparedness Interdepartmental/Agency Governance Agreement. The primary scope of the Agreement is the management of specific horizontal issues and/or initiatives relating to avian and pandemic influenza preparedness.
The Agreement is supported by a structure that falls within the auspices of the Deputy Minister's Committee on Avian and Pandemic Influenza Planning. Implementation of the Agreement is led by the Avian and Pandemic Influenza Assistant Deputy Ministers (API ADM) Governance Committee focusing on implementation of the initiatives. The API ADM Governance Committee provides strategic direction and oversight monitoring.
An Avian and Pandemic Influenza Operations Directors General Committee supports the API ADM Governance Committee, makes recommendations to it and oversees the coordination of deliverables.
Planning Highlights: In 2012–13 the collaborative efforts of the Agency, Health Canada and the Canadian Food Inspection Agency, will continue to clarify, communicate and test federal emergency management roles, responsibilities and mechanisms, with particular attention to the sustainability of response capacity and decision-making roles. These efforts will also improve the health portfolio's ability to communicate science to various audiences. Planned activities and expected results reflect lessons learned from the H1N1 pandemic, notably the Management Response and Action Plan (MRAP) following the Senate study.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Science and Technology for Public Health | Rapid vaccine development and testing | Ongoing | 1.0 | ER 1.1 |
Winnipeg lab and space optimization | Ongoing | 13.2 | ER 1.2 | |
Surveillance and Population Health Assessment | Surveillance | Ongoing | 8.7 | ER 2.1 ER 2.2 |
Public Health Preparedness and Capacity | Vaccine readiness and clinical trials | Ongoing | 3.6 | ER 3.1 |
Capacity and Emergency Preparedness | Ongoing | 12.2 | ER 4.1 ER 4.2 ER 4.3 |
|
Laboratory network and communications capacity | Ongoing | 3.0 | ER 5.1 | |
Influenza research network |
Ongoing | 5.8 | ER 6.1 | |
Pandemic influenza risk assessment and modelling | Ongoing | 0.8 | ER 7.1 | |
Skilled national public health workforce | Ongoing | 5.9 | ER 8.1 | |
Regulatory Enforcement and Emergency Response | Contribution to National Antiviral Stockpile | Ongoing | 0.1 | ER 9.1 |
Total Agency | 54.3 |
Expected Results for 2012–13:
ER 1.1: Canada conducts relevant research to better understand influenza pathogenesis (how the virus produces disease), further interrogate the virus (antiviral susceptibility, vaccine effectiveness), develop possible vaccine candidates, and epidemiology (how the virus spreads) to mitigate impact and improve capacity against future pandemic influenza viruses.
ER 1.2: Construction of the 5,300-m2 new laboratory is completed; increased high importance research capacity.
ER 2.1: Respiratory and vaccine preventable diseases and vaccine safety are monitored and reported in a timely manner.
ER 2.2: Canada is able to identify, mitigate and control of disease transmission at the initial outbreak stage in order to reduce the potential impact of influenza epidemics and pandemics.
ER 3.1: Canada has access to a supply of pandemic influenza vaccine.
ER 4.1: Canada has access to a supply of antivirals.
ER 4.2: Canada is able to prepare for and anticipate risks associated with novel influenza strains.
ER 4.3: Canada has the capacity to carry out public health interventions including emergency response and a maintained state of readiness of the Health Portfolio's Emergency Operations Centre.
ER 5.1: Canada has the public health capacity (including infrastructure, technical expertise, training and stakeholder communications strategies) to prepare and respond to pandemic influenza.
ER 6.1: Canada has access to a rapid response research mechanism for pandemic influenza research questions.
ER 7.1: Predictive and assessment models used for pandemic preparedness are developed and established.
ER 8.1: The work of Public Health Officers at placement sites improves their skills and increases local and regional public health organizations' capacity to respond to health emergencies, while enhancing collaborative working relationships between stakeholders and PHAC.
ER 9.1: The National Antiviral Stockpile is maintained and plans are established for the replacement of antiviral stocks as they reach the end of their shelf-life.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Health Products | Regulatory activities related to pandemic influenza vaccine | Ongoing | 1.2 | ER 10.1 |
Resources for review and approval of antiviral drug submissions for treatment of pandemic influenza | Ongoing | 0.2 | ER 11.1 | |
Establishment of a crisis risk management unit for monitoring and post-market assessment of therapeutic products | Ongoing | 0.3 | ER 12.1 | |
Health Infrastructure Support for First Nations and Inuit | Strengthen federal public health capacity through Governance and Infrastructure Support to FN/I Health System | Ongoing | 0.7 | ER 13.1 |
FN/I emergency preparedness, planning, training and integration | Ongoing | 0.3 | ER 14.1 | |
Specialized Health Services | Public health emergency preparedness and response (EPR) on conveyances | Ongoing | 0.2 | ER 15.1 |
Total HC | 3.0 |
Note: Totals may not add due to rounding
Expected Results for 2012–13:
ER 10.1: Policies, guidance and protocols are relevant for pandemic influenza; coordinated communications among jurisdictions with stakeholders and the public.
ER 11.1: Provision of timely, appropriate choice anti-virals and vaccines that meet the highest standards of safety, quality and efficacy.
ER 12.1: Timely and effective post-market monitoring and assessment of health products.
ER 13.1: Enhanced collaboration with Aboriginal Affairs, Northern Development Canada and the Public Health Agency of Canada as well as provincial/territorial partners on joint emergency preparedness and response (EPR) activities (including strengthening, testing and revising on-reserve First Nation pandemic plans). Strengthened links with key stakeholders to facilitate the integration of pandemic plans into all-hazards EPR plans.
ER 14.1: Continue to support the testing and revision of community pandemic plans based on H1N1 lessons learned.
ER 15.1: Coordination of policy and programs (including the emergency call system) for emergency preparedness and response related to pandemic influenza, quarantineable events and public health emergencies of international concern for conveyances, goods, cargo, and ancillary services.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Animal Health and Zoonotics Program / Internal Services | Ongoing | 20.3 | ER 16.1 ER 16.2 ER 16.3 ER 16.4 ER 16.5 ER 16.6 ER 16.7 ER 16.8 ER 16.9 |
|
Total CFIA | 20.3 |
Expected Results for 2012–13:
ER 16.1: Increased human resource capacity to support risk mitigation procedures (such as enhanced screening of live birds or poultry products) at Canada's ports of entry.
ER 16.2: Enhanced stakeholder and the general public knowledge and awareness of the poultry industry service sector.
ER 16.3: Enhanced/integrated Canadian surveillance system to ensure timely identification of potential outbreaks and response to avian influenza situations. Targeted wild bird surveillance plan for 2012 is currently being reviewed.
ER 16.4: During inter-pandemic periods, strengthen regulatory capacity, utilize performance measurement tools to identify areas for improvement, and continue proactive and coordinated risk communications related to biosecurity and disease prevention.
ER 16.5: A trained, skilled and equipped workforce ready to respond to potential avian influenza and animal disease outbreaks.
ER 16.6: Improve, through investment in research, federal capacity for the control, risk assessment, diagnostics, modelling, and vaccine component of avian influenza issues to enhance evidence-based decision-making on avian influenza responses and the effectiveness of disease control measures to help mitigate risks to human health and economic loss.
ER 16.7: Continue to provide assistance to the World Organisation for Animal Health (OIE) Central Bureau in the Communications Department in an effort to promote the development and implementation of science based standards. CFIA continues to support the OIE's mandate and efforts to assist member countries in the control and eradication of animal diseases, including zoonotics, through its annual contribution to the OIE. In addition, the CFIA continues to support the development of capacity to address emergence of risk at the animal level through the Canadian chapter of Veterinarians Without Borders. Work continues to harmonize diagnostic approaches, response and market access related issues associated with AI.
ER 16.8: Maintaining, coordinating and managing the Canadian Animal Health Surveillance Network, an integrated network of federal, provincial and university labs. This network allows for rapid testing, detection and reporting of AI.
ER 16.9: Continued development of a viable response plan for avian influenza and animal disease outbreaks, including HR capacity, and data management tools.
Results to be Achieved by Non-Federal Partners (if Applicable): N/A
Contact Information:
Dr. John Spika
130 Colonnade Road
Ottawa ON K1A 0K9
613-948-7929
john.spika@phac-aspc.gc.ca
Name of Horizontal Initiative: Canadian HIV Vaccine Initiative
Name of Lead Department(s): Public Health Agency of Canada (the Agency)
Lead Department Program Activity: Disease and Injury Prevention and Mitigation
Start Date of the Horizontal Initiative: February 20, 2007
End Date of the Horizontal Initiative: March 31, 2017
Total Federal Funding Allocation (Start to End Date): $111 M
Description of the Horizontal Initiative (Including Funding Agreement): The Canadian HIV Vaccine Initiative (CHVI) is a collaborative undertaking between the Government of Canada (GoC) and the Bill & Melinda Gates Foundation (BMGF) to contribute to the global effort to develop a safe, effective, affordable and globally accessible HIV vaccine. This collaboration, formalized by a Memorandum of Understanding signed by both parties in August 2006 and renewed in July 2010, builds on the Government of Canada's commitment to a comprehensive, long-term approach to address HIV/AIDS. Participating federal departments and agencies are the Agency, Health Canada, Industry Canada, the Canadian International Development Agency, and the Canadian Institutes of Health Research.
The CHVI's overall goals are to: advance the basic science of HIV vaccine discovery and social research in Canada and low-and-middle-income countries (LMICs); support the translation of basic science discoveries into clinical research, with a focus on accelerating clinical trials in humans; address the enabling conditions to facilitate regulatory approval and community preparedness; improve the efficacy and effectiveness of HIV Prevention of Mother-to-Child (PMTCT) services in LMICs by determining innovative strategies and programmatic solutions related to enhancing the accessibility, quality, and uptake; and ensure horizontal collaboration within the CHVI and with domestic and international stakeholders.
Shared Outcome(s):
Immediate (1–3 years) Outcomes
Intermediate Outcomes
Long-Term Outcomes
Governance Structure(s):
The Minister of Health, in consultation with the Minister of Industry and the Minister of International Cooperation, is the lead Minister for the CHVI. An Advisory Board will be established and be responsible for making recommendations to responsible Ministers regarding projects to be funded and will oversee the implementation of the Memorandum of Understanding between the GoC and the BMGF. The CHVI Secretariat, housed in PHAC will continue to provide a coordinating role to the GoC and the BMGF.
Planning Highlights: CHVI-participating Departments and Agencies will further initiatives commenced in 2011–12. For example, improved domestic and international research projects, as well as the Alliance Coordinating Office will continue to be supported. Plans for 2012–13 include the completion of the development stage of the Discovery and Social Research Large Team Grants Funding Opportunity. The Government of Canada and the Bill & Melinda Gates Foundation will continue to work together to define areas of investment to accelerate the development of a safe, effective, affordable and accessible HIV vaccine as one of the key priorities.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Disease and Injury Prevention and Mitigation | Infectious Disease Prevention and Control | 18.0 | 2.1 | ER 1.1 ER 2.1 ER 3.1 ER 3.2 |
Total PHAC | 18.0 | 2.1 |
Expected Results for 2012–13:
ER 1.1: Continue to support domestic and international efforts related to the research and development of an HIV vaccine.
ER 2.1: Develop an approach to access the HIV Vaccine Translational Support Fund to provide researchers with financial and project management support for translating HIV vaccine candidates from pre-clinical development research to small scale human clinical trials.
ER 3.1: Support the continued work of the Alliance Coordinating Office (ACO) to establish a strong and vibrant network of HIV vaccine researchers and other vaccine researchers both in Canada and internationally.
ER 3.2: Ensure effective communications, strategic planning, coordination, reporting and evaluation within the Government of Canada.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Internal Services | Governance and Management Support Services | 1.0 | 0.1 | ER 4.1 |
Health Products | Regulatory Capacity Building Program for HIV Vaccines | 4.0 | 0.8 | ER 5.1 |
Total HC | 5.0 | 0.9 |
Expected Results for 2012–13:
ER 4.1: Increased regulatory convergence and exchange of domestic and international best practices, policies and protocols related to the regulation of vaccines, with a focus on HIV/AIDS vaccines.
ER 5.1: Increased regulatory readiness and strengthened capacity of regulatory authorities in LMICs in to the area of vaccine products and clinical trials through training and the establishment of a mentorship program.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Commercialization and Research and Development Capacity in Targeted Canadian Industries | Industrial Research Assistance Program's Canadian HIV Technology Development Component | 13.0 | 2.5 | ER 6.1 |
Total IC | 13.0 | 2.5 |
Expected Results for 2012–13:
ER 6.1: New and innovative technologies for the prevention, treatment and diagnosis of HIV in pre-commercial development are advanced at small and medium-sized enterprises operating in Canada.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Global Engagement and Strategic Policy | International Development Assistance Program | 60.0 | 13.3 | ER 7.1 ER 8.1 ER 9.1 ER 10.1 |
Total CIDA | 60.0 | 13.3 |
Expected Results for 2012–13:
ER 7.1: Increased capacity to conduct high-quality clinical trials of HIV vaccine and other related prevention technologies in LMICs through new teams of Canadian and LMIC's researchers and research institutions.
ER 8.1: In collaboration with CIHR, increased capacity and greater involvement and collaboration amongst researchers working in HIV vaccine discovery and social research in Canada and in LMICs through the successful completion of the development stage of the Team Grant program to support collaborative teams of Canadian and LMIC researchers.
ER 9.1: Increased number of women accessing high quality PMTCT services.
ER 10.1: Increased capacity of regulatory authorities in LMICs, especially those where clinical trials are planned or ongoing, through training and networking initiatives.
Federal Partner Program Activity | Names of Programs for Federal Partners | Total Allocation (from Start to End Date) | Planned Spending for 2012–13 | Expected Results for 2012–13 |
---|---|---|---|---|
Health and Health Services Advances | Institute Strategic Advances – HIV/AIDS | 15.0 | 2.9 | ER 11.1 ER 11.2 ER 11.3 ER 11.4 |
Total CIHR | 15.0 | 2.9 |
Expected Results for 2012–13:
ER 11.1: In collaboration with CIDA, increased research outcomes in discovery and social research in HIV vaccines through the successful implementation of CHVI Large Teams of Canadian and LMIC researchers.
ER 11.2: Greater support for new ideas, concepts, approaches and technologies in HIV by developing and launching funding opportunities in basic vaccine research.
ER 11.3: Increased cadre of young Canadian and LMIC vaccine researchers, through the development and launch of funding opportunities in vaccine research and ongoing support to funded CHVI large teams.
ER 11.4: Enhanced linkages and efficiencies amongst researchers funded within this initiative by promotion of mechanisms for networking and information sharing (such as data sharing platforms and global intellectual property access mechanisms) to support the production of new knowledge and the translation of research findings into improvements in health and the health care system.
Results to be Achieved by Non-Federal Partners (if Applicable): Non-governmental stakeholders (including research institutions and not-for-profit community organizations) are integral to the success of the CHVI. Their role is to engage and collaborate with participating departments and agencies, the Bill & Melinda Gates Foundation and other funders to contribute to the CHVI goals and to Canada's contribution towards the Global HIV Vaccine Enterprise.
Contact Information:
Marsha Hay-Snyder
200 Eglantine Driveway
Ottawa, Ontario K1A 0K9
613-957-1345
marsha.hay-snyder@phac-aspc.gc.ca
Program Activity | Forecast Revenue 2011–12 |
Planned Revenue | ||
---|---|---|---|---|
2012–13 | 2013–14 | 2014–15 | ||
1.6 Regulatory Enforcement and Emergency Response Sale to federal and provincial territorial departments and agencies, airports and other federally regulated organizations of first aid kits to be used in disaster and emergency situations ($50,000) |
0.1 | 0.1 | 0.1 | 0.1 |
Subtotal | 0.1 | 0.1 | 0.1 | 0.1 |
Total Respendable Revenue | 0.1 | 0.1 | 0.1 | 0.1 |
Program Activity | Forecast Spending 2011–12 |
Planned Spending | ||
---|---|---|---|---|
2012–13 | 2013–14 | 2015–16 | ||
1.1 Science and Technology for Public Health | 21.2 | 14.9 | 5.0 | 4.5 |
1.6 Regulatory Enforcement and Emergency Response | 2.2 | 2.2 | 2.2 | 0.5 |
Total | 23.4 | 17.1 | 7.2 | 5.0 |
Note: All figures are rounded.
The following audits were included in the Risk Based Audit Plan 2011-2014 approved in June 2011. The plan is reviewed annually. The annual review and update on planned audits may result in modification to audits conducted.
Name of Internal Audit | Internal Audit Type | Status | Expected Completion Date |
---|---|---|---|
Audit of Immunization Program | Program | In Progress | June 2012 |
Audit of Values and Ethics and Conflict of Interest | Internal Services | Planned | September 2012 |
OCG Horizontal Audit on Compliance to the Policy on Management, Resources and Results Structures | Internal Services | Planned | December 2012 |
Audit of Financial Resources Allocation Process | Internal Services | Planned | December 2012 |
Audit of Observatory of Best Practices |
Program | Planned | March 2013 |
Audit of Coordination of Surveillance Activities |
Program | Planned | June 2013 |
Audit of Business Continuity Planning | Internal Services | Planned | September 2013 |
Audit of Risk Management Framework |
Internal Services | Planned | December 2013 |
Audit of Regional Operations | Program | Planned | December 2013 |
Audit of Talent Management in Public Health |
Program | Planned | March 2014 |
Audit of Surveillance Systems | Program | Planned | March 2014 |
Electronic Link to Internal Audit Plan: N/A
Name of Evaluation | Program Activity | Status | Expected Completion Date |
---|---|---|---|
Evaluation of Public Health Surveillance | 1.2.1 – Public Health Surveillance | In Progress | March 2013 |
Evaluation of Community Associated Infections Program | 1.5.3.3 – Community Associated Infections | Planned | March 2013 |
Evaluation of Mental Health Promotion Program | 1.4.1.3 – Mental Health Promotion | Planned | March 2013 |
Evaluation of Injury Prevention and Mitigation Program | 1.5.2 – Injury Prevention and Mitigation | Planned | March 2013 |
Evaluation of Canadian Public Health Service | 1.3.1 – Public Health Capacity | Planned | March 2013 |
Evaluation of Travel and Migration Health Program | 1.3 – Public Health Preparedness and Capacity 1.6 – Regulatory Enforcement and Emergency Response |
Planned | March 2014 |
Evaluation of Antimicrobial Resistance | 1.5 – Disease and Injury Prevention and Mitigation | Planned | March 2014 |
Evaluation of the Fetal Alcohol Spectrum Disorder Program | 1.4.3.4 – Fetal Alcohol Spectrum Disorder | Planned | March 2014 |
Evaluation of Public Health Tools Program | 1.3.1.2 – Public Health Tools | Planned | March 2014 |
Evaluation of the Federal Initiative on HIV/AIDS | 1.2 – Surveillance and Population Health Assessment 1.3 – Public Health Preparedness and Capacity 1.5 – Disease and Injury Prevention and Mitigation |
Planned | March 2014 |
Evaluation of Immunization and Respiratory Infections | 1.5.3.1 – Immunization 1.5.3.2 – Respiratory Infections |
Planned | March 2014 |
Evaluation of the Pathogens and Toxins Program | 1.6.1.3 – Pathogens and Toxins | Planned | March 2014 |
Evaluation of the Population Health Assessment Program | 1.2.2 – Population Health Assessment | Planned | March 2015 |
Evaluation of the Integrated Strategy for Healthy Living and Chronic Disease Programs | 1.5.1 – Chronic Disease Prevention and Mitigation 1.4.1.1 – Health Living |
Planned | March 2015 |
Evaluation of Emerging Priorities in Chronic Disease Prevention and Mitigation Program | 1.5.1.5 – Emerging Priorities in Chronic Disease Prevention and Mitigation | Planned | March 2015 |
Evaluation of Innovative Interventions | 1.4.2.2 – Innovative Interventions | Planned | March 2015 |
Evaluation of Stakeholder Engagement | 1.3.3 – Public Health Networks Includes additional funding areas | Planned | March 2015 |
Evaluation of the Field Services Program | 1.2.1.3 – Surveillance of Infectious Disease 1.3.1 – Public Health Capacity 1.3.2.2 – Emergency Preparedness 1.5.3.1 – Immunization 1.6.1.1 – Quarantine 1.6.2.3 – Mobile Laboratories |
Planned | March 2015 |
Electronic Link to Evaluation Plan: N/A